Correction to: REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal.

Authors :: Batista, S.
Nunes, C. C.
Cerqueira, J. J.
Silva, Ana Martins
de Sá, J. Correia
Ferreira, J.
Mendonça, M. T.
Pinheiro, J.
Salgado, V.
Correia, A. S.
Sequeira, J.
Costa, A.
Sousa, L.
Source :: Neurological Sciences; 2021, Vol. 42 Issue 2, p767-767, 1p
Publication Year :: 2021
Abstract: The article "REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal". [ABSTRACT FROM AUTHOR]

Full Text Access

Tools